A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

被引：0
作者：
Cinzia Pellegrini
Anna Dodero
Annalisa Chiappella
Federico Monaco
Debora Degl’Innocenti
Flavia Salvi
Umberto Vitolo
Lisa Argnani
Paolo Corradini
Pier Luigi Zinzani
机构：
[1] University of Bologna,Institute of Hematology “L. e A. Seràgnoli”
[2] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[3] Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino,undefined
[4] A.O. SS Antonio e Biagio e Cesare Arrigo,undefined
来源：
Journal of Hematology & Oncology | / 9卷
关键词：
Peripheral T-cell lymphoma; Relapsed; Refractory; Gemcitabine; Romidepsin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 409 条
[31]  
Jang SS(undefined)undefined undefined undefined undefined-undefined
[32]  
Shin HR(undefined)undefined undefined undefined undefined-undefined
[33]  
Park BH(undefined)undefined undefined undefined undefined-undefined
[34]  
Huh J(undefined)undefined undefined undefined undefined-undefined
[35]  
d’Amore F(undefined)undefined undefined undefined undefined-undefined
[36]  
Relander T(undefined)undefined undefined undefined undefined-undefined
[37]  
Lauritzsen GF(undefined)undefined undefined undefined undefined-undefined
[38]  
Jantunen E(undefined)undefined undefined undefined undefined-undefined
[39]  
Hagberg H(undefined)undefined undefined undefined undefined-undefined
[40]  
Anderson H(undefined)undefined undefined undefined undefined-undefined
12345678910